Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patch testing with a standard allergen ("screening") tray: rewards and risks.

Donald V Belsito1

  • 1Division of Dermatology, University of Kansas Medical Center, Kansas City, 66160-7319, USA. dbelsito@kumc.edu

Dermatologic Therapy
|June 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety Assessment of <i>Melaleuca alternifolia</i> (Tea Tree)-Derived Ingredients as Used in Cosmetics.

International journal of toxicology·2026
Same author

Safety Assessment of Radish Root - Derived Ingredients as Used in Cosmetics.

International journal of toxicology·2026
Same author

Amended Safety Assessment of Naturally-Sourced Clays as Used in Cosmetics.

International journal of toxicology·2026
Same author

Safety Assessment of Diatomaceous Earth as Used in Cosmetics.

International journal of toxicology·2026
Same author

Safety Assessment of Basic Yellow 87 as Used in Cosmetics.

International journal of toxicology·2026
Same author

Safety Assessment of Glycolactones as Used in Cosmetics.

International journal of toxicology·2026
Same journal

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Dermatologic therapy·2024
Same journal

Correction to "Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".

Dermatologic therapy·2022
Same journal

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.

Dermatologic therapy·2022
Same journal

A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.

Dermatologic therapy·2022
Same journal

High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.

Dermatologic therapy·2022
Same journal

Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.

Dermatologic therapy·2022
See all related articles

The TRUE Test panels are FDA-approved devices for diagnosing allergic contact dermatitis (ACD). They effectively identify common allergens, aiding in diagnosis and improving patient quality of life.

Area of Science:

  • Dermatology
  • Allergology

Background:

  • Allergic contact dermatitis (ACD) significantly impacts quality of life.
  • Accurate diagnosis is crucial for effective management.
  • Patch testing is the definitive diagnostic method for ACD.

Purpose of the Study:

  • To review the appropriate use of the TRUE Test panels.
  • To highlight the diagnostic utility of TRUE Test in detecting ACD.
  • To discuss factors influencing test accuracy and allergen relevance.

Main Methods:

  • Review of the TRUE Test panels, the only FDA-approved patch testing devices in the US.
  • Analysis of the 42 unique allergens and four complex mixtures included.
  • Discussion of patient evaluation rates and diagnostic performance.

Related Experiment Videos

Main Results:

  • TRUE Test panels are robust in detecting ACD, evaluating 28% of patients fully.
  • The panels cover a fraction of known allergens but are highly effective.
  • Common causes of false-positive and false-negative reactions are identified.

Conclusions:

  • Appropriate use of TRUE Test panels is essential for accurate ACD diagnosis.
  • Determining the relevance of positive reactions is critical.
  • TRUE Test panels identify the majority of relevant allergic reactions from common product exposures.